06.04.2023 • NewsIneosMitsuiphenol

Ineos Completes Mitsui Phenols Singapore Acquisition

Ineos Phenol announces the completion of its acquisition of the entire asset base of Mitsui Phenols Singapore from Mitsui Chemicals, a leading Japanese chemicals manufacturer, for a total consideration of $330 million.

© Ineos
© Ineos

The business has a turnover of $750 million and produces over 1 million tonnes of product each year, including cumene (410 kt/a), phenol (310 kt/a), acetone (185 kt/a) alpha-methylstyrene (20 kt/a) and bisphenol A (150 kt/a). 120 employees will now become part of Ineos Phenol.

Ineos Phenol stated that the addition of the Jurong phenol and BPA assets provide a good fit with its existing asset portfolio and expertise and presents significant integration opportunities with Ineos’ manufacturing sites in Germany, Belgium and the United States.

“Entering the Asian market via this acquisition gives Ineos Phenol a unique capability to support our global customers’ plans for future growth whilst at the same time we look forward to developing new markets and customer relationships associated with bisphenol A which will be a new product for Ineos,” said Gordon Adams, Business Director Ineos Phenol.

Phenol, acetone, alpha-methyl styrene and BPA are used in the production of polycarbonate, plastics, phenolic resins, synthetic fibres and solvents. These products are used in a diverse range of end markets, including the automotive, construction, electronics, healthcare, surgical and fibre industries.  

Ineos Phenol is the largest producer of phenol and acetone with operating assets in Germany, Belgium and USA all supported by a dedicated research and technology centre based in Germany.

Author: Dede Williams, Freelance Journalist

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.